CONy 2014 Webcasting Saturday
|
Click here for Hall A – STROKE
Click here for Hall C – HEADACHE Click here for Hall C - PARKINSON'S DISEASE Click here for Hall D – EPILEPSY |
 |
|
SATURDAY, MAY 10, 2014 |
|||
 |
|||
 |
 |
 |
 |
|
Management of intracranial vascular pathology Debate: Is thrombectomy an effective therapy for acute stroke? No: Louis Caplan, USA |
Management of intracranial vascular pathology Debate: Is thrombectomy an effective therapy for acute stroke? Discussion |
Management of intracranial vascular pathology Debate: Is thrombectomy an effective therapy for acute stroke? Commentator: M. Rajappa Sivakumar, India |
Management of intracranial vascular pathology Debate: Is thrombectomy an effective therapy for acute stroke? Yes: Daniel Bereczki, Hungary |
|
|
|||
 |
 |
 |
 |
|
Management of intracranial vascular pathology Debate: Is hemostatic therapy the most promising treatment option for ICH? Discussion |
Management of intracranial vascular pathology Debate: Is hemostatic therapy the most promising treatment option for ICH? Commentator: László Csiba, Hungary |
Acute stroke management Debate: Cryptogenic stroke: Immediate anticoagulation or long-term ECG recording? Immediate anticoagulation: Hans-Christoph Diener, Germany |
Acute stroke management Debate: Cryptogenic stroke: Immediate anticoagulation or long-term ECG recording? Long-term ECG recording: Tommaso Sanna, Italy |
|
|
|||
 |
 |
 |
|
|
Acute stroke management Debate: Cryptogenic stroke: Immediate anticoagulation or long-term ECG recording? Discussion |
Acute stroke management Debate: Cryptogenic stroke: Immediate anticoagulation or long-term ECG recording? Commentator: Ashfaq Shuaib, Canada |
Acute stroke management Debate: Stroke prevention after AF-associated stroke Open questions with the new anticoagulants: Hans-Christoph Diener, Germany |
Acute stroke management Debate: Stroke prevention after AF-associated stroke Discussion |
|
|
|
|
|
 |
 |
 |
 |
|
Acute stroke management Debate: Stroke prevention after AF-associated stroke Commentator: Natan Bornstein, Israel |
Personalized treatment of neurological diseases, Michael R. Hayden, Israel |
Stroke: Acute and chronic treatment Debate: Intracranial artery stenosis: Medical vs. endovascular (stent) treatment Medical: Patrik Michel, Switzerland |
Stroke: Acute and chronic treatment Debate: Intracranial artery stenosis: Medical vs. endovascular (stent) treatment Endovascular: Marius Hartmann, Germany |
|
|
|||
 |
 |
 |
 |
|
Stroke: Acute and chronic treatment Debate: Intracranial artery stenosis: Medical vs. endovascular (stent) treatment Discussion |
Stroke: Acute and chronic treatment Debate: Intracranial artery stenosis: Medical vs. endovascular (stent) treatment Commentator: Louis Caplan, USA |
Stroke: Acute and chronic treatment Debate: Is transcranial magnetic brain stimulation effective in improving recovery after stroke? Yes: Dieter Heiss, Germany |
Stroke: Acute and chronic treatment Debate: Is transcranial magnetic brain stimulation effective in improving recovery after stroke? No: John C. Rothwell, UK |
|
|
|||
 |
 |
 |
 |
|
Stroke: Acute and chronic treatment Debate: Is transcranial magnetic brain stimulation effective in improving recovery after stroke? Discussion |
Stroke: Acute and chronic treatment Debate: Is transcranial magnetic brain stimulation effective in improving recovery after stroke? Commentator: Judit Málly, Hungary |
Secondary stroke prevention Debate: Dual or mono antiplatelet early after TIA or minor stroke? Dual: Jonathan Streifler, Israel |
Secondary stroke prevention Debate: Dual or mono antiplatelet early after TIA or minor stroke? Mono: Christian Weimar, Germany |
|
|
|
|
|
 |
 |
 |
 |
|
Secondary stroke prevention Debate: Dual or mono antiplatelet early after TIA or minor stroke? Discussion |
Secondary stroke prevention Debate: Dual or mono antiplatelet early after TIA or minor stroke? Commentator: Ashfaq Shuaib, Canada |
Secondary stroke prevention Debate: Asymptomatic carotid reconstruction before CABG – Yes or no? Yes: Christian Weimar, Germany |
Secondary stroke prevention Debate: Asymptomatic carotid reconstruction before CABG – Yes or no? No: László Csiba, Hungary |
|
|
|
|
|
 |
 |
|
|
|
Secondary stroke prevention Debate: Asymptomatic carotid reconstruction before CABG – Yes or no? Discussion |
Secondary stroke prevention Debate: Asymptomatic carotid reconstruction before CABG – Yes or no? Commentator: Jonathan Streifler, Israel |
|
|
|
|
|
|
|
|
|
|||
 |
 |
 |
 |
|
Molecules in headache and sleep Debate: CGRP antibodies will become the treatment choice for chronic migraine Pro: Lars Edvinsson, Sweden |
Molecules in headache and sleep Debate: CGRP antibodies will become the treatment choice for chronic migraine Commentator: Uwe Reuter, Germany |
Molecules in headache and sleep Debate: CGRP antibodies will become the treatment choice for chronic migraine Discussion |
Molecules in headache and sleep Debate: Orexin modulators are critical for treating insomnia Pro: Marcelo Bigal, USA |
|
|
|||
 |
 |
 |
 |
|
Molecules in headache and sleep Debate: Orexin modulators are critical for treating insomnia Con: Hans Hamburger, The Netherlands |
Molecules in headache and sleep Debate: Orexin modulators are critical for treating insomnia Commentator: Alan Rapoport, USA |
Molecules in headache and sleep
Debate: Orexin modulators are critical for treating insomnia Discussion |
Molecules in headache and sleep Debate: Innovative headache treatments will be better than what we currently have Pro: Uwe Reuter, Germany |
|
|
|||
 |
 |
 |
 |
|
Molecules in headache and sleep Debate: Innovative headache treatments will be better than what we currently have Con: Zaza Katsarava, Germany |
Molecules in headache and sleep Debate: Innovative headache treatments will be better than what we currently have Commentator: Elliott Gross, USA |
Molecules in headache and sleep Debate: Innovative headache treatments will be better than what we currently have Discussion |
Molecules in headache and sleep Debate: The use of placebo is essential in headache trials No: Peter Kropp, Germany |
|
|
|||
 |
 |
 |
 |
|
Molecules in headache and sleep Debate: The use of placebo is essential in headache trials Commentator: Marcelo Bigal, USA |
Molecules in headache and sleep Debate: The use of placebo is essential in headache trials Discussion |
Treatment of chronic headache Debate: Electrical stimulation is an important advance in the treatment of headache disorders Yes: Arne May, Germany |
Treatment of chronic headache Debate: Electrical stimulation is an important advance in the treatment of headache disorders No: László Vécsei, Hungary |
|
|
|||
 |
|
 |
 |
|
Treatment of chronic headache Debate: Electrical stimulation is an important advance in the treatment of headache disorders Discussion |
Treatment of chronic headache Debate: Behavioral therapy is efficacious and sufficient for the treatment of migraine and chronic migraine Con: Hans-Christoph Diener, Germany |
Treatment of chronic headache Debate: Behavioral therapy is efficacious and sufficient for the treatment of migraine and chronic migraine Commentator: Alan Rapoport, USA |
Treatment of chronic headache Debate: Behavioral therapy is efficacious and sufficient for the treatment of migraine and chronic migraine Discussion |
|
|
|||
|
|
|
 |
|
|
The meaning of migraine for life … Debate: Is migraine a critical risk factor in stroke Pro: László Vécsei, Hungary |
The meaning of migraine for life … Debate: Is migraine a critical risk factor in stroke Con: Hans-Christoph Diener, Germany |
The meaning of migraine for life … Debate: Is migraine a critical risk factor in stroke Commentator: Stefan Evers, Germany |
The meaning of migraine for life … Debate: Is migraine a critical risk factor in stroke Discussion |
|
|
|||
|
|
 |
 |
 |
|
The meaning of migraine for life … Debate: Does migraine confer an evolutionary advantage to migraineurs? Yes: Peter Kropp, Germany |
The meaning of migraine for life … Debate: Does migraine confer an evolutionary advantage to migraineurs? No: Jack Schim, USA |
The meaning of migraine for life … Debate: Does migraine confer an evolutionary advantage to migraineurs? Commentator: Lars Edvinsson, Sweden |
The meaning of migraine for life … Debate: Does migraine confer an evolutionary advantage to migraineurs? Discussion |
